Table 1

Demographic and clinical characteristics of the patients with tracheal carcinoma in situ included in the study

PatientSexSmoking (pack years)Initial malignancy (stage)*SiteAge (surgery)Site(s) of new tumour (histology/time to diagnosis†)Sites testedSpecimens analysed
1M60SqCC (T1N0M0)LUL58Left completion pneumonectomy (SqCC) arising from a region of LUL stump (M93)1946
2M30–40SqCC (T1N0M0)LLL72LLL stump (SqCC/M48)68
Right Lung (SqCC/M50)
LUL (CIS /M78)
Trachea (SD /M85)
3M47SqCC (T1N0M0)LUL66Lower Trachea/LMB stump (both early invasive SqCC/M42)56
4M40SqCC (T2N0M0)RUL57RUL stump (SqCC/M11)
Trachea posterior wall
(invasive SqCC/M11)
33
5M40SqCC (T1N0)RML RLL70RIB (CIS /M60)67
  • *Refers to initial malignancy detected prior to patient's referral to UCLH.

  • †Refers to the time interval between surgery and diagnosis of new SqCC/CIS.

  • CIS, carcinoma in situ; LLL, left lower lobe; LMB, left main bronchus; LUL, left upper lobe; RIB, right intermediate bronchus; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe; SqCC, squamous cell carcinoma; SD, severe dysplasia; UCLH, University College London Hospital.